CASMED - CAS Medical Systems, Inc. of Branford, CT at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

CASMED - CAS Medical Systems, Inc.

44 E. Industrial Road, 06405 Branford, CT
USA

This company is co-exhibitor of
U.S. Department of Commerce, U.S. Commercial Service

Hall map

MEDICA 2018 hall map (Hall 16): stand C04

Fairground map

MEDICA 2018 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.06  Intense medicine / anesthesiology / respiration
  • 01.06.03  Patient monitoring systems

Patient monitoring systems

Our products

Product category: Patient monitoring systems

ABOUT OUR TISSUE OXIMETRY PRODUCTS

WHEN CEREBRAL OXIMETRY TECHNOLOGY LAUNCHED commercially in 1993, it promised to provide insight into what some have referred to as the black box of the brain – by providing an objective assessment of the oxygenation of the brain.

While the first cerebral oximetry devices showed some promise, they failed to provide the level of accuracy and precision that was necessary to maximize their usefulness as a standard component of anesthesia management. This, coupled with design limitations of the initial devices led to a loss of confidence and relevance among some clinicians and early adopters, which may still remain today.
HOWEVER, CASMED CONTINUED TO BELIEVE in the promise and future of cerebral oximetry and continued to invest time and resources into developing, refining, enhancing, and validating the technology since 1999.

The first FORE-SIGHT monitor, launched in 2007, utilized four wavelengths of NIR light as opposed to two, generating exponentially better accuracy when compared to alternative devices. The current generation of FORE-SIGHT – FORESIGHT ELITE – now uses five wavelengths of light, along with additional design enhancements to ensure the most accurate readings on the market, allowing cerebral oximetry to finally be used as originally intended: a critical component of any anesthesia management protocol when used in the OR.

FORE-SIGHT PROVIDES ABSOLUTE, ACTIONABLE READINGS that detect cerebral desaturations so consistently and reliably that physicians are empowered to intervene or stay the course with confidence.

THE MOST WAVELENGTHS
5 wavelengths of NIR light to collect more and better data
UNPARALLELED ACCURACY+ PRECISION
Consistently providing the best picture of the patient’s actual cerebral oxygen status
A CUSTOMIZED ALGORITHM
Fine-tuned to specific tissue beds and able to compensate for substances such as melanin
THE DEEPEST LIGHT PENETRATION
Unique sensor design provides up to 2.5 cm of light penetration.
TECHNOLOGY TAILORED FOR ALL PATIENTS
Pediatric solutions to accommodate your tiniest patients.
FORE-SIGHT – The confidence of knowing®.

More Less

About us

Company details

VISION & VALUES
CASMED provides high-quality tissue oximetry products to hospitals, emergency medical services, and original equipment manufacturers (OEMs).

Our Vision
Our vision is that no patient is harmed by undetected tissue hypoxia.

That’s why we developed FORE-SIGHT ELITE tissue oximetry – the most accurate, noninvasive measure of tissue oxygenation in the world.

Our Values
We strongly believe that our values drive the quality of our products:

We shall act with integrity in all that we do.
We are committed to the highest standards of ethical, professional and regulatory conduct, and will strive always to "do the right thing".

Improving patient care is our passion.
An unyielding commitment to quality is a requirement, and we shall embrace ideas and innovation that permit clinicians to improve patient care.

Excellence is our standard.
We shall strive to be the best we can be, constantly seeking opportunities to improve and conducting our business with competitive urgency.

The CASMED team is our greatest asset.
We will respect and empower our co-workers because we know we win together, or lose together.

We are accountable.
We will honor our commitments to all our stakeholders including our co-workers, customers, suppliers, partners and shareholders.

More Less